In structured products, structuring is not just a technical function, it is the discipline that determines whether an idea works in practice, across market conditions, regulatory environments and client portfolios.
At Marex Financial Products, structuring has long been approached as a risk-first, client-led process, rather than a product-led one. Before payoffs are discussed, the focus is on understanding constraints: how risk behaves under stress, how exposures interact within a portfolio, and how a solution fits within governance and operational realities.
This philosophy is what differentiates Marex’s structuring capability.
A non-bank approach to structuring
Unlike traditional investment banks, Marex operates as a non-bank issuer with a flexible, cross-asset operating model and global market presence. This independence shapes how structuring is done.
Structuring is guided by client objectives and portfolio realities, rather than predefined product agendas. This allows solutions to be designed around specific goals, from yield within a defined risk budget to volatility overlays, thematic exposure or capital-efficient diversification.
This independence also enables an agile approach. Structuring teams work closely with trading and risk management, allowing ideas to be tested, priced and refined quickly as markets move.
Cross-asset, portfolio-driven design
As client mandates become more specific, structuring increasingly needs to operate across asset classes. Marex Financial Products structuring capability spans exotics, quantitative investment strategies (QIS), credit, volatility and thematic solutions, enabling a more holistic approach.
Rather than structuring around single tickers or isolated trades, solutions are designed around how they interact with a broader portfolio. This is particularly relevant for more complex use cases — such as options on funds, credit-linked notes, or crypto-related structures — where traditional bank platforms often struggle to offer flexibility.
This portfolio-driven mindset has become a key advantage as clients look beyond standard autocallables toward more bespoke, risk-aware solutions.
Strengthening our structuring capabilities
Kerim Haddad joins Marex Solutions as Head of Structuring, working across exotics and QIS structuring and contributing to broader strategic initiatives.
With nearly two decades of experience across Global Markets, Kerim brings expertise in complex product structuring, risk management and leading international teams across EMEA, the Americas and APAC. That experience fits naturally with Marex’s cross-asset, globally informed approach to structuring.
Kerim’s role is not to change how structuring works at Marex, but to operate within — and contribute to — a model that is already defined by agility, collaboration and client focus. His appointment reflects the growing importance of structuring as a strategic capability as demand increases for more sophisticated, customised outcomes.
Structuring as a differentiator
Across regions, clients increasingly expect structurers to move beyond product templates and deliver solutions that reflect real-world constraints. This includes:
- Designing structures that remain resilient under stress
- Adapting quickly as market conditions change
- Aligning solutions with regulatory, capital and operational frameworks
- Providing clarity around risk, payoff behaviour and lifecycle management
Structuring is how these expectations are met. It is embedded into how teams collaborate, how risks are managed, and how solutions are delivered at scale without losing flexibility.
As structured products continue to evolve toward more investor-led design, structuring remains central to Marex Financial Products’ value proposition, serving not as a standalone function but as the foundation of how the business operates.
Interested in discussing tailored structured solutions?
Let’s talk
This article has been prepared by Marex for information purposes only.
Information in this article should not be considered as advice, or as a recommendation or solicitation to purchase or otherwise deal in securities, investments or any other products. The article does not take into account particular investment objectives, risk appetites, financial situations or needs. Recipients of the article should make their own trading or investment decisions based upon their own financial objectives and financial resources.
This article may contain forward-looking statements including statements regarding our intent, belief or current expectations with respect to Marex’s businesses and operations, market conditions, results of operation and financial condition, capital adequacy, specific provisions and risk management practices. Readers are cautioned not to place undue reliance on these forward-looking statements which may be subject to change without notice. While reasonable care has been used in the preparation of forecast information, actual results may vary in a materially positive or negative manner. Forecasts and hypothetical examples are subject to uncertainty and contingencies outside Marex’s control. Past performance is not a reliable indication of future performance.
The information contained herein is current as at the date of publication. No part of this article may be redistributed, copied or reproduced without prior written consent of Marex. While reasonable care has been taken to ensure that the facts stated are fair, clear and not misleading, Marex does not warrant or represent (expressly or impliedly) their accuracy or completeness. Any opinions expressed may be subject to change without notice. Marex accepts no liability whatsoever for any direct, indirect or consequential loss or damage arising out of the use of all or any of the data or information in this article.
This article was approved by Marex Financial (“MF”). MF is incorporated under the laws of England and Wales (company no. 5613061, LEI no. 5493003EETVWYSIJ5A20 and VAT registration no. GB 872 8106 13) and is authorised and regulated by the Financial Conduct Authority (FCA registration number 442767). MF’s registered address is at 155 Bishopsgate, London, EC2M 3TQ.
The Marex® group of companies includes Marex Financial (including the Marex Solutions division), Marex Spectron International Limited, CSC Commodities UK Limited, Tangent Trading Limited, Marex Spectron Europe Limited, Marex North America LLC, Marex Capital Markets Inc, Marex Spectron USA LLC, Spectron Energy Inc., Marex Australia Pty Ltd, Marex MENA Limited, Marex Hong Kong Limited, Marex Spectron Asia Pte. Ltd., Spectron Energy (Asia) Pte. Ltd., Marex France SAS (including the BIP AM division), X-Change Financial Access, LLC, Starsupply Petroleum Europe B.V., Volcap Trading Partners Limited, Volcap Trading Partners France SAS and Arfinco S.A (individually and collectively “Marex”).
© 2025 Marex. All rights reserved.
